Table of Contents
Advances in Anesthesiology
Volume 2015 (2015), Article ID 708915, 6 pages
http://dx.doi.org/10.1155/2015/708915
Research Article

Effect of Low and High Dose Sugammadex on the Coagulation and Fibrinolytic System in Rats

1Department of Anesthesiology, Faculty of Medicine, Ordu University, 52100 Ordu, Turkey
2Department of Biochemistry, Faculty of Medicine, Ordu University, 52100 Ordu, Turkey
3Department of Anesthesiology, Faculty of Medicine, Ondokuz Mayıs University, 55139 Samsun, Turkey
4Department of Biochemistry, Ordu State Hospital, 52100 Ordu, Turkey

Received 19 April 2015; Accepted 25 May 2015

Academic Editor: Ming-Hwang Shyr

Copyright © 2015 Nilay Taş et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Bom, F. Hope, S. Rutherford, and K. Thomson, “Preclinical pharmacology of sugammadex,” Journal of Critical Care, vol. 24, no. 1, pp. 29–35, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. L. M. Staals, H. D. de Boer, J. van Egmond et al., “Reversal of rocuronium-induced neuromuscular block by sugammadex is independent of renal perfusion in anesthetized cats,” Journal of Anesthesia, vol. 25, no. 2, pp. 241–246, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. T. Gaszynski, T. Szewczyk, and W. Gaszynski, “Randomized comparison of sugammadex and neostigmine for reversal of rocuronium-induced muscle relaxation in morbidly obese undergoing general anaesthesia,” British Journal of Anaesthesia, vol. 108, no. 2, pp. 236–239, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000885/WC500052310.pdf.
  5. T. M. Hemmerling, C. Zaouter, G. Geldner, and D. Nauheimer, “Sugammadex—a short review and clinical recommendations for the cardiac anesthesiologist,” Annals of Cardiac Anaesthesia, vol. 13, no. 3, pp. 206–216, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Raft, J.-F. Betala Belinga, G. Jurkolow, E. Desandes, D. Longrois, and C. Meistelman, “Clinical evaluation of post-surgical bleeding after a sugammadex injection,” Annales Francaises d'Anesthesie et de Reanimation, vol. 30, no. 10, pp. 714–717, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. S. J. Schaller and H. Fink, “Sugammadex as a reversal agent for neuromuscular block: an evidence-based review,” Core Evidence, vol. 8, pp. 57–67, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. G. Cammu, P.-J. De Kam, K. De Graeve et al., “Repeat dosing of rocuronium 1.2 mg kg−1 after reversal of neuromuscular block by sugammadex 4.0 mg kg−1 in anaesthetized healthy volunteers: a modelling-based pilot study,” British Journal of Anaesthesia, vol. 105, no. 4, pp. 487–492, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. I. F. Sorgenfrei, K. Norrild, P. B. Larsen et al., “Reversal of rocuronium-induced neuromuscular block by the selective relaxant binding agent sugammadex: a dose-finding and safety study,” Anesthesiology, vol. 104, no. 4, pp. 667–674, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. H. J. M. Lemmens, M. I. El-Orbany, J. Berry, J. B. Morte Jr., and G. Martin, “Reversal of profound vecuronium-induced neuromuscular block under sevoflurane anesthesia: sugammadex versus neostigmine,” BMC Anesthesiology, vol. 10, article 15, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. R. K. Mirakhur, “Sugammadex in clinical practice,” Anaesthesia, vol. 64, no. 1, pp. 45–54, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. N. Bhasin and R. I. Parker, “Diagnostic outcome of preoperative coagulation testing in children,” Pediatric Hematology-Oncology, vol. 31, no. 5, pp. 458–466, 2014. View at Publisher · View at Google Scholar
  13. P. Gabriel, X. Mazoit, and C. Ecoffey, “Relationship between clinical history, coagulation tests, and perioperative bleeding during tonsillectomies in pediatrics,” Journal of Clinical Anesthesia, vol. 12, no. 4, pp. 288–291, 2000. View at Publisher · View at Google Scholar · View at Scopus
  14. E. Sokół-Kobielska, “Sugammadex—indications and clinical use,” Anaesthesiology Intensive Therapy, vol. 45, no. 2, pp. 106–110, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. P. J. de Kam, P. Grobara, M. Prohn et al., “Effects of sugammadex on activated partial thromboplastin time and prothrombin time in healthy subjects,” International Journal of Clinical Pharmacology and Therapeutics, vol. 52, no. 3, pp. 227–236, 2014. View at Google Scholar
  16. P.-J. de Kam, R. El Galta, A. C. Kruithof et al., “No clinically relevant interaction between sugammadex and aspirin on platelet aggregation and coagulation parameters,” International Journal of Clinical Pharmacology and Therapeutics, vol. 51, no. 12, pp. 976–985, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. M. B. C. Koh and B. J. Hunt, “The management of perioperative bleeding,” Blood Reviews, vol. 17, no. 3, pp. 179–185, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Thomas and M. D. Habermann, “Hematology,” in Mayo Clinic Internal Medicine; Concise Textbook, T. M. Habermann and A. K. Ghosh, Eds., pp. 379–383, CRC Press, 2008. View at Google Scholar
  19. B. T. Somuk, H. Soyalıç, S. Koc, L. Gürbüzler, S. Doğru, and A. Eyibilen, “Mean platelet volume as an inflammatory marker of chronic otitis media with effusion,” International Journal of Pediatric Otorhinolaryngology, vol. 78, no. 11, pp. 1958–1960, 2014. View at Publisher · View at Google Scholar
  20. S. G. Chu, R. C. Becker, P. B. Berger et al., “Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysis,” Journal of Thrombosis and Haemostasis, vol. 8, no. 1, pp. 148–156, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. N. Rahe-Meyer, H. Fennema, S. Schulman et al., “Effect of reversal of neuromuscular blockade with sugammadex versus usual care on bleeding risk in a randomized study of surgical patients,” Anesthesiology, vol. 121, no. 5, pp. 969–977, 2014. View at Publisher · View at Google Scholar
  22. M. Carron, “Effects of sugammadex on coagulation: it does not represent a bleeding risk in surgicalpatients,” International Journal of Clinical Pharmacology and Therapeutics, vol. 52, no. 9, p. 824, 2014. View at Google Scholar
  23. S. J. A. Gold and N. J. N. Harper, “The place of sugammadex in anaesthesia practice,” Trends in Anaesthesia and Critical Care, vol. 2, no. 1, pp. 4–9, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. S. J. Brull and M. Naguib, “Selective reversal of muscle relaxation in general anesthesia: focus on sugammadex,” Drug Design, Development and Therapy, no. 3, pp. 119–129, 2009. View at Google Scholar · View at Scopus
  25. L. P. H. Yang and S. J. Keam, “Sugammadex: a review of its use in anaesthetic practice,” Drugs, vol. 69, no. 7, pp. 919–942, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. T. Fuchs-Buder, C. Meistelman, and J. Raft, “Sugammadex: clinical development and practical use,” Korean Journal of Anesthesiology, vol. 65, no. 6, pp. 495–500, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. T. Lisman, S. H. Caldwell, A. K. Burroughs et al., “Hemostasis and thrombosis in patients with liver disease: the ups and downs,” Journal of Hepatology, vol. 53, no. 2, pp. 362–371, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. L. M. Staals, M. M. J. Snoeck, J. J. Driessen, E. A. Flockton, M. Heeringa, and J. M. Hunter, “Multicentre, parallel-group, comparative trial evaluating the efficacy and safety of sugammadex in patients with end-stage renal failure or normal renal function,” British Journal of Anaesthesia, vol. 101, no. 4, pp. 492–497, 2008. View at Publisher · View at Google Scholar · View at Scopus